To the best of our knowledge, our study is the first attempt to investigate whether the action of quercetin may have potential therapeutic efficacy for the treatment of AMD through the regulation of mtROS homeostasis by deacetyl-SOD2 through the Nrf2-PGC-1α-Sirt1 signaling pathway. This evidence concerns the gene PPARGC1A and age-related macular degeneration.